One of the major ailments plaguing the world's dairy sector is bovine mastitis. Whether it is clinical or subclinical, this infection can result in financial losses owing to decreased milk production, milk discarding, and treatment costs [8, 22–23]. It is crucial to be constantly aware that organisms found in raw milk samples can act as pathogens, commensals, or contaminants. The S. aureus and CNS can both be found in raw milk without increasing SCC, and as a result, they can also be found on the extramammary sites, which is why they are frequently associated with intramammary infection (IMI) [24–25]. This study used a variety of culture, biochemical, and PCR approaches to identify several staphylococcal species in raw milk samples from dairy cows with subclinical mastitis.
According to CMT and SCC at the quarter level, subclinical mastitis prevalence in the current research was 56 and 54%, respectively. According to [26–27] this observed prevalence is comparatively lower than the previously recorded in other regions of Africa, such as Uganda, Kenya, and Ethiopia, at 86.2%, 64%, and 59.2% respectively.
In addition to the aforementioned, further analysis bases on bacterial culture approach of the raw milk samples determined the predominant staphylococcal species isolates from dairy cows with subclinical mastitis. The analysis revealed that t every sample had staphylococcal species. The MALDI-TOF MS and biochemical tests were employed to identify these species. According to the findings, a total of 62 (68.8%) isolates were discovered in 90 quarter milk samples using both the culture technique and the RapID STAPH plus system. The isolates were identified using the MALDI-TOF Ms method and 16S rDNA. The overall findings are consistent with those of Wald et al., [8] and Hosseinzadeh and Dastmalchi Saei [28], who used similar approaches to analyze the staphylococci presence in quarter samples of raw milk.
Our MALDI-TOF MS findings revealed that S. aureus (38/76%) was a dominating species occurring in most of the samples, followed by S. epidermidis (2/4%), S. chromogenes (6/12%), and S. haemolyticus (2/4%). The research conducted by Braga et al., [9] and Nonnemann et al., [29], who both sought to discover subclinical mastitis pathogens in raw milk, supports these findings. The current study's findings are consistent with the assertion made by Braga et al., [29], that using of MALDI-TOF MS in conjunction with the Biotyper software is a superior approach for identifying Staphylococcus species. Furthermore, the current study supported Mahmmod et al., [30] findings, indicating that we may utilize this technique to further detect CNS. However, despite the effectiveness and efficiency of the MALDI-TOF system, Banach et al., [31] reported that some staphylococci strains, including S. sciuri (3 strains), S. xylosus (2 strains), and S. equorum (1 strain), cannot be identified to the species level but can instead be identified using other techniques. This was consistent with numerous studies reporting on this MALDI-TOF system limitation [32]. It is also proposed that sample preparation, number of reference strains, bacterial growing conditions, and the software version of Biotyper may all contribute to the identification of CNS [33–34].
As validated by Kosecka-Strojek et al., [35], our 16S rRNA Sanger sequencing indicated that S. aureus (76%) was the dominantly isolated staphylococcal species, followed by 38/50, S. chromogenes (10%), S. agnetis (4%) S. argenteus (4%) and S. devriesei (1%). Using a variety of diagnostic methods (Biochemical, MALDI-TOF and 16S rDNA sequencing), the current investigation found that S. aureus was the predominant bacterium identified from subclinical mastitis cows. It is important to remember that the CNS were also segregated. In humans, S. aureus is widespread [14, 36]. According to evidence from Egypt, S. aureus is the pathogen most likely to cause mastitis, followed by S. agalactiae and E. coli [37–38]. Other authors, however, who isolated S. aureus with incidences of 77.1% and 52.5%, respectively, reported greater detection rates [39–40]. Numerous publications have utilized various PCR-based techniques for the identification of S. aureus isolates from different sources [41–42]. According to Brakstad et al. [43], all the S. aureus isolates examined had an amplicon size of more than 1,250 bp when the gene encoding a S. aureus-specific portion of the 16S rRNA was amplified, which supports the current study.
The epidemiology of CNS mastitis and the effects of certain species are more debatable in comparison to the contagiousness of the majority of S. aureus and effective programs to control S. aureus IMI. Identification of species may be important for mastitis control programs, management practices, and decisions about therapeutic techniques when CNS are found in quarter milk samples [8, 44]. Eleven distinct Staphylococcus species isolated from samples of cow's milk were identified using RapID STAPH PLUS system, MALDI-TOF MS and 16S rDNA Sanger sequencing. These include S. chromogenes, S. epidermidis, S. haemolyticus, S. aureus, S. capitis sp. Urealyticus, S warneri, S. intermedius, S. agnetis, S. argenteus, S. devriesei and S. xylosus [45].The major CNS species identified in the current analysis were S. chromogenes, which is consistent with studies conducted in Switzerland and Austria, with an average herd size 30 cows [46]. Furthermore, Taponen and Pyörälä [5], showed that CNS species (apart from S. chromogenes) isolated from teat surface, apex, and canal predominantly differ from the CNS species isolated from milk.
Although this study contributes to our knowledge of different Staphylococcus strains, the relative relevance of each strain is still up for discussion. The prevalence of Staphylococcus hyicus IMI was extremely low, and the order of frequency did not match that of studies conducted in other areas. This was attributed to a variety of factors influencing pathogen distribution, including variations in management practices and housing, study design, schematic milk sampling, the definition of IMI, and not using molecular methods for species identification [10]. According to a recent example by Calcutt et al. [47], a number of isolates that had previously been classified as S. hyicus would probably be reclassified as S. agnetis. Historically, Staphylococcus hyicus was listed as one of the frequently isolated CNS species, in part due to misclassification and the fact that S. chromogenes was erroneously classified as a subspecies of S. hyicus. [10].
It is highly desirable to accurately identify staphylococci at the species level in order to determine host-pathogen relationships more precisely and to better understand the pathogenic potential of various staphylococcal species in light of the growing clinical significance of CNS [14]. Therefore this indicates that phenotypic identification of CNS is inadequate, unreliable, and non-replicable [48–52]. Therefore, to enhance the identification process, genetic approaches must be used in conjunction to the conventional microbiological diagnostics. For the majority of staphylococcal species, the 16S rRNA gene is an acceptable target for sequencing; nevertheless, for other species, inter-species distinction is challenging or impossible due to a lack of or inadequate heterogeneity within the 16S rRNA. Most studies demonstrate that for closely related Staphylococcus species, 16S rRNA gene sequencing's discriminatory strength is extremely poor [48, 53–55]. However, the poor quality of many of the sequences uploaded to public databases hinders the accuracy of bacterial species identification using 16S rRNA gene sequencing. Compared to 16S rRNA gene sequencing, other high throughput sequencing techniques may have a better identification potential, but they are frequently restricted to a small number of taxa [16]. In the future, whole-genome sequencing might replace current conventional methods for characterizing CNS species [51].